Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P50583 (
asymmetrical
)
12,197
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Embryos have evolved various strategies to confine the action of secreted signals. Using an HRP-Wingless fusion protein to track the fate of endocytosed Wingless, we show that degradation by targeting to lysosomes is one such strategy. Wingless protein is specifically degraded at the posterior of each stripe of wingless transcription, even under conditions of overexpression. If lysosomal degradation is compromised genetically or chemically, excess Wingless accumulates and ectopic signaling ensues. In the wild-type, Wingless degradation is slower at the anterior than at the posterior. This follows in part from the segmental activation of signaling by the
epidermal growth factor receptor
, which accelerates Wingless degradation at the posterior, thus leading to
asymmetrical
Wingless signaling along the anterior-posterior axis.
...
PMID:Regulated endocytic routing modulates wingless signaling in Drosophila embryos. 1138 31
The
epidermal growth factor receptor
(
EGFR
) plays a key role in regulating cell proliferation, migration, and differentiation, and aberrant
EGFR
signaling is implicated in a variety of cancers.
EGFR
signaling is triggered by extracellular ligand binding, which promotes
EGFR
dimerization and activation. Ligand-binding measurements are consistent with a negatively cooperative model in which the ligand-binding affinity at either binding site in an
EGFR
dimer is weaker when the other site is occupied by a ligand. This cooperativity is widely believed to be central to the effects of ligand concentration on
EGFR
-mediated intracellular signaling. Although the extracellular portion of the human
EGFR
dimer has been resolved crystallographically, the crystal structures do not reveal the structural origin of this negative cooperativity, which has remained unclear. Here we report the results of molecular dynamics simulations suggesting that
asymmetrical
interactions of the two binding sites with the membrane may be responsible (perhaps along with other factors) for this negative cooperativity. In particular, in our simulations the extracellular domains of an
EGFR
dimer spontaneously lay down on the membrane in an orientation in which favorable membrane contacts were made with one of the bound ligands, but could not be made with the other. Similar interactions were observed when
EGFR
was glycosylated, as it is in vivo.
...
PMID:Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor. 2505 6